Go
Print

Chapter 69.77 RCW

INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES

Sections
Findings—Intent.
Definitions.
Eligible patient and treating physician may request investigational product—Manufacturer may make for treatment—Agreement.
Patient eligibility for access and treatment with investigational product.
Informed consent.
Issuer may provide coverage for cost or administration of investigational product—Denial of coverage.
Hospitals and health care facilities.
Private right of action—Unprofessional conduct—Immunity from civil or criminal liability.
Pharmacy quality assurance commission may adopt rules.
Site Contents
Selected content listed in alphabetical order under each group



Translate